Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats - Wikidata - awgldk - TriplyDB

Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats

Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats

http://www.wikidata.org/entity/Q35564256

about

Endothelial Progenitor Cells in Diabetic Microvascular Complications: Friends or Foes?Incretin-Based Therapy for Prevention of Diabetic Vascular Complications Animal models of peripheral neuropathies Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats Protection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection.Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas.Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury Potential role of intravitreal human placental stem cell implants in inhibiting progression of diabetic retinopathy in type 2 diabetes: neuroprotective growth factors in the vitreous GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice Physiology of incretins in health and disease.Protection of trigonelline on experimental diabetic peripheral neuropathy.Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity.The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems.Extra-pancreatic effects of incretin-based therapies.DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control.Therapeutic effect of exendin-4, a long-acting analogue of glucagon-like peptide-1 receptor agonist, on nerve regeneration after the crush nerve injury.Exenatide promotes regeneration of injured rat sciatic nerve Pioglitazone and exenatide enhance cognition and downregulate hippocampal beta amyloid oligomer and microglia expression in insulin-resistant rats.GLP-1 receptor agonist liraglutide reverses long-term atypical antipsychotic treatment associated behavioral depression and metabolic abnormalities in rats.Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy.GLP1 and GIP are involved in the action of synbiotics in broiler chickens.Comparison of sensory tests and neuronal quantity of peripheral nerves between streptozotocin (STZ)-induced diabetic rats and paclitaxel (PAC)-treated rats.Neurotrophic and neuroprotective properties of exendin-4 in adult rat dorsal root ganglion neurons: involvement of insulin and RhoA.

P2860

Q26745523-11168C52-45B9-4F6F-9812-761CB5A87CFC Q26765470-5FC64F50-CECE-42D3-AAA8-EFF91A40B30F Q27028046-289FA21A-341E-48E3-9865-823A0F457679 Q28481242-3A0C609B-8ED4-46D8-BDE9-5FF48EEB6C01 Q28550675-CCFF6DF5-D2A6-4531-86EC-8DFB36285186 Q30390165-4F2B128F-58E5-46A6-AFCB-0AF9F0FA6DDF Q33603384-2BCA137D-C9F7-4002-BF09-50A9FE1C7121 Q34362412-AF102912-5C66-47DF-83F7-9F1BD541C7F1 Q35015877-12A0FC99-ECEF-4F4C-9F81-3772F8FEB58F Q35226164-0244B32C-0B0A-45C6-8DD3-D855D44E21BE Q35760279-FF5E6911-6F08-47E6-9ECC-9097EEAD270C Q36477770-37D03DB7-9DAB-4623-8CB6-961446DD95D9 Q38122004-901CC3D6-12D7-46F8-A531-E02BA7A5ACB5 Q38174279-C3380B79-AF24-45E1-BF46-75B2F71E9454 Q38194069-430CAAA8-8A36-440E-B9A4-C0BE4773B9FE Q38922177-3EAB1B52-D64B-4AE4-B372-DC60C861AFE3 Q42181887-29ED939C-57BE-42EF-A2F7-EDA426C40ABD Q42258261-4A0AAFEC-30D2-417F-AE9A-4D9B7EF19A79 Q46734353-E4FC90F2-6D4D-4347-B0A9-1F1447886CEA Q48254506-EF78B4A7-D8AB-48D4-822B-6BB706AB898D Q48511577-DD729F58-F1F5-4F50-AC9E-D74038112C2E Q49695428-CF03F3AF-BC73-467D-BA51-61F7A8C21D2B Q51378923-0C4D58B5-6928-42C1-BEFB-123772F53394 Q53486609-D03F83C7-9B8B-4352-B854-54E838499F0C

P2860

Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats

http://www.wikidata.org/entity/Q35564256

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Neuroprotective effect of the ...... ozotocin-induced diabetic rats

@ast

Neuroprotective effect of the ...... ozotocin-induced diabetic rats

@en

type

label

Neuroprotective effect of the ...... ozotocin-induced diabetic rats

@ast

Neuroprotective effect of the ...... ozotocin-induced diabetic rats

@en

prefLabel

Neuroprotective effect of the ...... ozotocin-induced diabetic rats

@ast

Neuroprotective effect of the ...... ozotocin-induced diabetic rats

@en

P1433

Q35564256-E6C56006-603C-40D4-B321-0403E39A9C1E

P1476

Q35564256-4E84393E-9E49-495A-94F7-F4A73C04D7A2

P2093

Q35564256-238243C6-4417-4D23-9348-22D1A54546A4

Q35564256-3756DAA4-66B8-4080-97B3-2270AC3DD47C

Q35564256-7978F296-A38E-4B82-ADBB-DA70595DCEE2

Q35564256-CFF3D84C-C533-4CB6-91CE-5EBA29A36DA0

Q35564256-DFFF3A71-BB59-45D1-A3E1-FA600B70D1A3

Q35564256-E6294E2F-0FB3-4959-893E-F67171B14377

P2860

Q35564256-0073DA67-80FC-4B28-ABF6-DE47B2266107

Q35564256-030760A6-DC08-4226-9F5E-47756389B832

Q35564256-0D3F7F13-FA5D-47B2-BDB7-C493B987A9F8

Q35564256-14D7F1E0-F44F-4291-B643-670BA9F5DB05

Q35564256-1765F755-8F84-4B45-ADA6-036F89269E19

Q35564256-21F7698C-E26A-46F9-AF6E-E29FFB39BEB4

Q35564256-26C29D8F-3E13-4F7E-B935-BE11E31A98A3

Q35564256-2968C03F-EA95-42CC-84E0-CDEBDBF1C95F

Q35564256-2D07E455-B959-4879-8D49-BB1EB627E8E1

Q35564256-3303B28B-80EF-441B-B02E-00E641DB7132

P304

Q35564256-7BF33FB9-4144-4165-AB6D-CA1C534E764D

P31

Q35564256-CE73CD0A-69DD-4EA4-934C-71C7FEEBE4AA

P356

Q35564256-DC1B6800-A99B-4411-B1B1-28A0764F5951

P407

Q35564256-22BD0582-C87E-460E-9F45-CAC9739580D3

P433

Q35564256-ED325229-CE48-478C-AB3F-A88529ECAFF7

P478

Q35564256-57B11ACC-7E84-4D6B-A570-00C8C8240C96

P577

Q35564256-DD482211-BBAF-4F93-B158-6385CC4C738A

P5875

Q35564256-D48AD1C4-749F-4143-B917-0889C6EC0533

P698

Q35564256-55514499-FF44-446A-87E0-C014C9C1D92C

P932

Q35564256-5A1207DE-9D7E-4DE8-818B-F7703213C688

P356

J.1476-5381.2011.01272.X

P1433

British Journal of Pharmacology

P1476

Neuroprotective effect of the ...... ozotocin-induced diabetic rats

@en

P2093

Heung Yong Jin

http://www.w3.org/2001/XMLSchema#string

Hong Sun Baek

http://www.w3.org/2001/XMLSchema#string

Kyung Ae Lee

http://www.w3.org/2001/XMLSchema#string

Shu Hua Xie

http://www.w3.org/2001/XMLSchema#string

Tae Sun Park

http://www.w3.org/2001/XMLSchema#string

Wei Jing Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis

The role of adjunctive exenatide therapy in pediatric type 1 diabetes.

Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.

GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.

The role of the Schwann cell in trophic support and regeneration.

GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells.

The glucagon-like peptides: a double-edged therapeutic sword?

Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis.

P304

1410-1420

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2011.01272.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

164

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49838605

http://www.w3.org/2001/XMLSchema#string

P698

21323903

http://www.w3.org/2001/XMLSchema#string

P932

3221096

http://www.w3.org/2001/XMLSchema#string